Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU

被引:98
作者
Fraser, GL
Prato, S
Riker, RR
Berthiaume, D
Wilkins, ML
机构
[1] Univ Vermont, Coll Med, Burlington, VT USA
[2] Maine Med Ctr, Dept Crit Care Med, Portland, ME 04102 USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 01期
关键词
D O I
10.1592/phco.20.1.75.34663
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To study the frequency, duration, severity, and treatment of agitation in patients in the intensive care unit (ICU) to determine if the elderly represent a distinct population. Design. Prospective cohort study. Setting. Tertiary care, 10-bed, multidisciplinary ICU. Patients. All patients older than 18 years of age admitted for longer than 24 hours during a Lt-month period. Interventions. None. Measurements and Main Results. One hundred thirty patients were studied for 916 patient-days; 63 (48%) were elderly (> 65 yrs). Nurses and physicians described agitated behavior in 92 patients (70.8%) during 534 (58.3%) patient-days, and it was severe or dangerous in 60 patients (46.1%) during 273 (30%) patient-days. There were no age-related differences in frequency, severity, and duration of agitation. Opiates, benzodiazepines, and haloperidol were administered during 72%, 62%, and 29% of agitated patient-days, respectively. Haloperidol was administered more often to elderly patients (p=0.015); otherwise no between-group differences were noted. Daily dosing requirements were less in the elderly for intermittent intravenous lorazepam, haloperidol, and morphine but not for midazolam (p=0.15). When these dosages were corrected for body mass, no statistical differences between young and old were found. Conclusion. In the ICU, the elderly are not a distinct population for agitation.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 39 条
[11]  
Durbin C G Jr, 1994, New Horiz, V2, P64
[12]   POSTOPERATIVE DELIRIUM - A REVIEW OF 80 PRIMARY DATA-COLLECTION STUDIES [J].
DYER, CB ;
ASHTON, CM ;
TEASDALE, TA .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (05) :461-465
[13]  
FISH DN, 1991, CLIN PHARMACY, V10, P456
[14]   AGING AND THE ANTICOAGULANT RESPONSE TO WARFARIN THERAPY [J].
GURWITZ, JH ;
AVORN, J ;
ROSSDEGNAN, D ;
CHOODNOVSKIY, I ;
ANSELL, J .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) :901-904
[15]   THE AMBIGUOUS RELATION BETWEEN AGING AND ADVERSE DRUG-REACTIONS [J].
GURWITZ, JH ;
AVORN, J .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (11) :956-966
[16]  
HANSENFLASCHEN J, 1994, CRIT CARE MED, V22, P732
[17]   IMPROVING PATIENT TOLERANCE OF MECHANICAL VENTILATION - CHALLENGES AHEAD [J].
HANSENFLASCHEN, J .
CRITICAL CARE CLINICS, 1994, 10 (04) :659-671
[18]   USE OF SEDATING DRUGS AND NEUROMUSCULAR BLOCKING-AGENTS IN PATIENTS REQUIRING MECHANICAL VENTILATION FOR RESPIRATORY-FAILURE - A NATIONAL SURVEY [J].
HANSENFLASCHEN, JH ;
BRAZINSKY, S ;
BASILE, C ;
LANKEN, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2870-2875
[19]  
Harvey M A, 1996, Am J Crit Care, V5, P7
[20]   PROPOFOL VERSUS MIDAZOLAM FOR INTENSIVE-CARE UNIT SEDATION AFTER CORONARY-ARTERY BYPASS-GRAFTING [J].
HIGGINS, TL ;
YARED, JP ;
ESTAFANOUS, FG ;
COYLE, JP ;
KO, HK ;
GOODALE, DB .
CRITICAL CARE MEDICINE, 1994, 22 (09) :1415-1423